ETF Holdings Breakdown of LFST

LFST institutional holdings

The adjusted close for LFST on 2025-11-12 was 6.44

The following institutional investment holdings of LFST have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-12	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	110,662	USD 712,663 -0.5%	6.44
2025-11-12	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	13,806 -0.3%	USD 88,911 -0.8%	6.44
Total =		124,468	USD 801,574

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with LFST

LifeStance Health Group (NASDAQ:LFST) vs. DaVita (NYSE:DVA) Financial Review

LifeStance Health Group (NASDAQ:LFST – Get Free Report) and DaVita (NYSE:DVA – Get Free Report) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends. Institutional and Insider Ownership 85.5% of LifeStance […] - 2025-09-11 02:15:15

Victory Capital Management Inc. Grows Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Victory Capital Management Inc. grew its stake in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 2,599.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 370,598 shares of the company’s stock after acquiring an additional 356,867 shares during the quarter. […] - 2025-07-29 04:22:52

BTIG Research Initiates Coverage on LifeStance Health Group (NASDAQ:LFST)

BTIG Research started coverage on shares of LifeStance Health Group (NASDAQ:LFST – Free Report) in a report published on Friday, MarketBeat.com reports. The firm issued a buy rating and a $8.00 price target on the stock. A number of other equities analysts also recently commented on the stock. KeyCorp began coverage on shares of LifeStance […] - 2025-07-28 04:22:50

LifeStance Health Group, Inc. (NASDAQ:LFST) Receives $8.50 Consensus Price Target from Brokerages

LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) has earned an average rating of “Moderate Buy” from the six analysts that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have assigned a buy rating and one has given a strong buy rating […] - 2025-07-17 04:40:51

LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. cut its stake in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 5.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,584,850 shares of the company’s stock after selling 203,856 shares during the period. Principal […] - 2025-07-09 05:51:37

Brokerages Set LifeStance Health Group, Inc. (NASDAQ:LFST) PT at $8.50

LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) has earned an average rating of “Moderate Buy” from the six analysts that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the […] - 2025-06-20 02:20:16

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 16.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 604,321 shares of the company’s stock […] - 2025-06-04 05:02:51

LifeStance Health Group (NASDAQ:LFST) Raised to Buy at UBS Group

LifeStance Health Group (NASDAQ:LFST – Get Free Report) was upgraded by analysts at UBS Group from a “neutral” rating to a “buy” rating in a research note issued on Tuesday, Marketbeat.com reports. The brokerage currently has a $8.50 target price on the stock. UBS Group’s target price suggests a potential upside of 40.73% from the […] - 2025-05-29 02:30:55

61,247 Shares in LifeStance Health Group, Inc. (NASDAQ:LFST) Bought by D. E. Shaw & Co. Inc.

D. E. Shaw & Co. Inc. purchased a new position in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) in the fourth quarter, Holdings Channel.com reports. The fund purchased 61,247 shares of the company’s stock, valued at approximately $451,000. Other institutional investors and hedge funds also recently added to or reduced their stakes in the […] - 2025-05-27 04:34:49

Analysts Set LifeStance Health Group, Inc. (NASDAQ:LFST) Price Target at $8.30

LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six research firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating, three have given a buy rating and one has […] - 2025-05-26 02:48:50

BNP Paribas Financial Markets Takes Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

BNP Paribas Financial Markets purchased a new position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) during the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 118,842 shares of the company’s stock, valued at approximately $876,000. A number of other hedge funds and other institutional investors have also recently made changes to […] - 2025-05-22 04:38:48

LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Bought by Invesco Ltd.

Invesco Ltd. lifted its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 30.3% during the 4th quarter, HoldingsChannel.com reports. The fund owned 162,146 shares of the company’s stock after acquiring an additional 37,718 shares during the quarter. Invesco Ltd.’s holdings in LifeStance Health Group were worth $1,195,000 as of its […] - 2025-05-02 04:15:05

Analysts Set LifeStance Health Group, Inc. (NASDAQ:LFST) Price Target at $8.30

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) have been given a consensus rating of “Moderate Buy” by the six research firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, three have issued a […] - 2025-05-01 02:50:47

Legal & General Group Plc Boosts Stake in LifeStance Health Group, Inc. (NASDAQ:LFST)

Legal & General Group Plc lifted its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 134,557 shares of the company’s stock after purchasing an additional 5,917 shares during the […] - 2025-04-28 04:55:10

Renaissance Technologies LLC Acquires 495,300 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

Renaissance Technologies LLC lifted its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 421.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 612,800 shares of the company’s stock after acquiring an additional 495,300 shares during the period. Renaissance […] - 2025-04-22 05:02:58

Geode Capital Management LLC Raises Stock Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Geode Capital Management LLC lifted its position in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 0.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,465,471 shares of the company’s stock after acquiring an additional 13,293 shares during the […] - 2025-04-18 04:34:52

LifeStance Health Group, Inc. (NASDAQ:LFST) Holdings Raised by Wellington Management Group LLP

Wellington Management Group LLP increased its stake in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 9.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,276,237 shares of the company’s stock after purchasing an additional 445,796 shares during the quarter. Wellington […] - 2025-04-07 05:26:56

13,053 Shares in LifeStance Health Group, Inc. (NASDAQ:LFST) Acquired by Cibc World Markets Corp

Cibc World Markets Corp purchased a new stake in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 13,053 shares of the company’s stock, valued at approximately $96,000. A number of other large investors […] - 2025-03-28 06:16:49

Keybank National Association OH Has $420,000 Stake in LifeStance Health Group, Inc. (NASDAQ:LFST)

Keybank National Association OH grew its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 86.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 56,974 shares of the company’s stock after buying an additional 26,412 shares during […] - 2025-03-10 05:53:03

LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Purchased by Rhumbline Advisers

Rhumbline Advisers increased its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 4.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 195,581 shares of the company’s stock after acquiring an additional 8,487 shares during […] - 2025-03-05 07:04:57

LifeStance Health Group, Inc. (NASDAQ:LFST) Receives $8.70 Consensus Target Price from Analysts

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy […] - 2025-03-05 04:40:45

Back to Listing

Disclaimer